Sluggish Prescription Drug Sales Leads Pharmaceutical Industry To Invest In Medical Compliance And Adherence Programs
An article in Drug Store News discusses possible solutions to combat dropping prescription drug sales and slowing drug development
New Haven, CT - February 25, 2009 - The last year has been a perfect storm of problems for pharmaceutical companies, pharmacies, and the drug industry at large: the world economy is faltering, new drug development is stalling, generic drugs are gaining popularity, and the Food and Drug Administration is tightening restrictions and slowing approval processes. With a strong headwind of bad circumstances, weak sales, and little development, the drug industry is looking for new, creative ways to combat their slowdown in growth.
The new routes to continued success that the industry is considering include patient outreach, patient education, screening programs, and compliance programs - all in hopes that consumers will regularly take the drugs already prescribed to them and begin new prescriptions as their health needs change.
"The drug industry's decision to direct considerable resources towards screening, education, and medical compliance programs is equally beneficial to pharmaceutical companies, retail pharmacies and patients," said Kevin Aniskovich, Chief Executive of the healthcare information technology company Intelecare, which specializes medical reminder solutions. "Medication non-compliance is the nation's biggest drug problem with one out of the every two patients failing to follow their physicians orders. With this latest industry trend, patients will hopefully acknowledge the ramifications and comply with the drug regime from their very first script."
According to the National Council for Patient Information and Education, over 50% of patients are noncompliant with their medication. This medical non-compliance leads to an estimated $300 billion in costs to the United States Health Care system and 125,000 deaths annually.
"Consistency in medication adherence is paramount to any effective drug regime," said Aniskovich. "A new focus on assisting patients to consistently take their drugs ensures that even the most chronic of diseases is held to a manageable degree."
To read the study in full, please visit http://www.drugstorenews.com
Established in 2005, Intelecare Compliance Solutions is a privately owned healthcare information technology company that provides an array of practical tools and services promoting medical adherence. With 84 percent of patients reporting forgetfulness as the major cause of non-compliance, and with the healthcare system suffering over $300 billion in costs annually due to non-compliance, Intelecare's solutions enable patients and caregivers alike to keep track of medications, doses, and doctor's appointments through the phone, mobile devices, and email - all while keeping simplicity, practicality, and innovation at the heart of its developments.
Aside from individual end-user services, Intelecare provides and manages a suite of scalable services for insurers, employers, retail pharmacies, non-profit organizations and pharmaceutical manufacturers. Currently supporting millions of subscribers, Intelecare is dedicated to finding functional solutions to the widespread issue of medical non-compliance for individuals around the world that work the way people live.
Intelecare in the News: Founder and CEO named to Top 100 people in Life-Sciences industry.
Click here to read more.
*Intelecare is a trademark of Intelecare Compliance Solutions, Inc. All other trademarks are the property of their respective owners.